Dimethylphenylpiperazinium
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
| Identifiers | |
|---|---|
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C12H19N2 |
| Molar mass | 191.29 g/mol |
| 3D model (JSmol) | |
| |
| |
| | |
Dimethylphenylpiperazinium (DMPP) is a nicotinic acetylcholine receptor agonist which is selective for the ganglionic subtype.[1] One of the earliest reports on the pharmacology of DMPP, describing it as a ganglion-stimulating, hypertensive agent, came from Graham Chen and his co-workers at Parke, Davis & Co.[2]
See also[edit]
References[edit]
- ^ Prado WA, Segalla DK (August 2004). "Antinociceptive effects of bethanechol or dimethylphenylpiperazinium in models of phasic or incisional pain in rats". Brain Res. 1018 (2): 272–82. doi:10.1016/j.brainres.2004.05.085. PMID 15276888.
- ^ G. Chen, R. Portman and A. Wickel (1951) J. Pharmacol. Exp. Ther. 103 (1951).
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Dimethylphenylpiperazinium&oldid=844366934"
Hidden categories:
- Articles with changed CASNo identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles